Document Detail


Cost-effectiveness analysis of preventing mother-to-child transmission of hepatitis B by injecting hepatitis B immune globulin.
MedLine Citation:
PMID:  22922527     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
OBJECTIVE: Hepatitis B immune globulin (HBIG) injection during pregnancy and/or after birth is an intervention for preventing mother-to-child transmission of the hepatitis B (HB) virus. However, varying cost-effectiveness ratios among various HBIG therapies remain unclear. This study explored these differences in cost-effectiveness ratios. METHODS: Four districts in Wuhan, China, were selected for the current study using stratified random sampling. Pregnant women who were positive for HB surface antigen (HBsAg) and who received prenatal care in district-level maternal and child health hospitals were interviewed. The mothers and their children underwent follow-up visits from the time of pregnancy until the children were six-and-a-half months old. RESULTS: A total of 324 cases completed the follow-up visits on a voluntary basis. Among the 324 HBsAg-positive pregnant women investigated, 60.49% (196/324) were injected with HBIG at different trimesters. A total of 249 neonates (76.85%) received an HBIG injection within 24 h after birth. The HBsAg-positive rate in infants was 5.56% (18/324). The HBIG-injected mother and infant group had the lowest chronic infection rate among children [odds ratio=0.14, 95% confidence interval (CI) 0.02-0.90, P=0.039]. The HBIG-injected infant group exhibited the lowest HBsAb-positive rate (odds ratio=0.07, 95% CI 0.02-0.23). The cost per averted disability-adjusted life years was lowest in the infant group: USD 118.61 (95% CI 105.23-131.99). CONCLUSION: These results indicate that active and passive immunizations (HBIG and HB vaccine) entail the lowest cost in the prevention of chronic HB infection in infants. However, this programme has the lowest HBsAb-positive rate, which possibly prevents children from self-acquiring antibodies.
Authors:
Yan Guo; Wei Zhang; Yu Zhang; Xiaofang Lin; Bin Zhang; Chong Chen; Yukai Du
Related Documents :
15178027 - Linkages between cellular biomarker responses and reproductive success in oysters--cras...
11573957 - Embryonic abnormalities from misexpression of cnscl1.
23720367 - Effect of multivitamin supplementation on measles vaccine response among hiv-exposed un...
16206567 - Comparison of three lines of broilers differing in ascites susceptibility or growth rat...
12682747 - Gastroschisis: determinants of neonatal outcome.
11471167 - Analysis of the ephx1 113 polymorphism and gstm1 homozygous null polymorphism and oral ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-8-23
Journal Detail:
Title:  European journal of gastroenterology & hepatology     Volume:  -     ISSN:  1473-5687     ISO Abbreviation:  Eur J Gastroenterol Hepatol     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-8-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9000874     Medline TA:  Eur J Gastroenterol Hepatol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
aDepartment of Maternal and Child Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology bWuhan Centers For Disease Prevention And Control dWuhan Medical Care Center for Women and Children, Wuhan, Hubei cCenter for Non-Infecious Liver Diseases, 302 Military Hospital, Beijing, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Partner Influence and In-Phase Versus Anti-Phase Physiological Linkage in Romantic Couples.
Next Document:  An Acquired Defect Associated with Abnormal Signaling of the Platelet Collagen Receptor Glycoprotein...